ArticleJournal of clinical medicine2018

SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment.

Yu-Hsiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.